The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.

Saved in:

Bibliographic Details
Title:	The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.
Authors:	Burger, Maximilian¹ maximilian.burger@klinik.uni-regensburg.de, Thiounn, Nicolas², Denzinger, Stefan¹, Kondas, Jozsef³, Benoit, Gerard⁴, Chapado, Manuel S.⁵, Jimenz-Cruz, Fernando J.⁶, Kisbenedek, Laszlo⁷, Szabo, Zoltán⁸, Zsolt, Domján⁸, Grimm, Marc O.⁹, Romics, Imre¹⁰, Thüroff, Joachim W.¹¹, Kiss, Tamas¹², Tombal, Bertrand¹³, Wirth, Manfred⁹, Munsell, Marc¹⁴, Mills, Bonnie¹⁵, Koh, Tung¹⁵, Sherman, Jeff¹⁶
Source:	Journal of Translational Medicine. 2010, Vol. 8, p54-59. 6p.
Database:	Academic Search Ultimate

Description
ISSN:	14795876
DOI:	10.1186/1479-5876-8-54